Clinical trial
A Phase II Study of High-Dose Melphalan With Hematopoietic Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis
NCT00003353 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of High-Dose Melphalan With Hematopoietic Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis
- Lead sponsor
- Eastern Cooperative Oncology Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 16, 1998
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma and plasma cell neoplasm